Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864]
International Immunopharmacology · 2026-11 · 117587
DOI: 10.1016/j.intimp.2026.117587 ↗Kurz gefasst
Korrektur in der Zeitschrift International Immunopharmacology, 2026-11. Verfasst von Lvwen Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Urology, Anhui Medical University, Hefei….
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Urology, Anhui Medical University, Hefei, China; Anhui Province Key Laboratory of Urological and Andrological…
Zitieren
APA
Zhang, L., Song, Z., Mao, X., Yang, Y., Hou, B., Chen, Y., & Hao, Z. (2026). Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864]. International Immunopharmacology, 117587. https://doi.org/10.1016/j.intimp.2026.117587
Vancouver
Zhang L, Song Z, Mao X, Yang Y, Hou B, Chen Y, et al. Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864]. International Immunopharmacology. 2026:117587. doi:10.1016/j.intimp.2026.117587
BibTeX
@article{Zhang2026,
author = {Zhang, Lvwen and Song, Zhenyu and Mao, Xike and Yang, Yuehan and Hou, Bingbing and Chen, Yang and Hao, Zongyao},
title = {Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864]},
journal = {International Immunopharmacology},
year = {2026},
pages = {117587},
doi = {10.1016/j.intimp.2026.117587}
}
EUVIMED